Three-Drug showdown for heart failure crisis
NCT ID NCT07372040
Summary
This study compares three different add-on medications (empagliflozin, acetazolamide, and metolazone) when given alongside standard diuretics to hospitalized patients with sudden worsening of heart failure. Researchers will measure how much urine patients produce over three days and track changes in blood and urine markers related to heart stress. The goal is to find which combination best helps remove excess fluid while monitoring safety and 30-day survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta university
RECRUITINGTanta, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.